Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Phibro Animal (S, US)  Pharmaceuticals
1. Phibro Animal (S, US)   Pharmaceuticals 91 31 25 56
2. Akorn (M, US)  Pharmaceuticals
2. Akorn (M, US)   Pharmaceuticals 76 78 46 67
3. SciClone Pharmaceuticals (XS, US)  Pharmaceuticals
3. SciClone Pharmaceuticals (XS, US)   Pharmaceuticals 73 67 46 56
4. Pernix Therapeutics (XS, US)  Pharmaceuticals
4. Pernix Therapeutics (XS, US)   Pharmaceuticals 56 1 62 22
5. AbbVie (XXL, US)  Biotechnology
5. AbbVie (XXL, US)   Biotechnology 51 88 16 58

January 6, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Heska (XS, US)   Pharmaceuticals
1. Heska (XS, US)   Pharmaceuticals 17 94 25 56
2. Amphastar (XS, US)   Pharmaceuticals
2. Amphastar (XS, US)   Pharmaceuticals 49 89 31 56
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology 51 88 16 58
4. Akorn (M, US)   Pharmaceuticals
4. Akorn (M, US)   Pharmaceuticals 76 78 46 67
5. SciClone Pharmaceuticals (XS, US)   Pharmaceuticals
5. SciClone Pharmaceuticals (XS, US)   Pharmaceuticals 73 67 46 56
6. Zoetis (XXL, US)   Pharmaceuticals
6. Zoetis (XXL, US)   Pharmaceuticals 39 67 31 44
7. Impax Laboratories (S, US)   Pharmaceuticals
7. Impax Laboratories (S, US)   Pharmaceuticals 46 67 15 44
8. Johnson & Johnson (XL, US)   Pharmaceuticals
8. Johnson & Johnson (XL, US)   Pharmaceuticals 39 66 24 40
9. Merck & Co. (XL, US)   Pharmaceuticals
9. Merck & Co. (XL, US)   Pharmaceuticals 30 62 76 72
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 17 60 94 74

January 6, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Vivus (XS, US)   Pharmaceuticals
1. Vivus (XS, US)   Pharmaceuticals 41 22 100 56
2. Nektar (S, US)   Pharmaceuticals
2. Nektar (S, US)   Pharmaceuticals 15 22 100 44
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 17 60 94 74
4. Merck & Co. (XL, US)   Pharmaceuticals
4. Merck & Co. (XL, US)   Pharmaceuticals 30 62 76 72
5. Eli Lilly (XL, US)   Pharmaceuticals
5. Eli Lilly (XL, US)   Pharmaceuticals 19 22 73 26
6. Endocyte (XS, US)   Pharmaceuticals
6. Endocyte (XS, US)   Pharmaceuticals 18 1 67 10
7. Pernix Therapeutics (XS, US)   Pharmaceuticals
7. Pernix Therapeutics (XS, US)   Pharmaceuticals 56 1 62 22
8. Pfizer (XL, US)   Pharmaceuticals
8. Pfizer (XL, US)   Pharmaceuticals 36 52 55 50

January 6, 2017. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
1. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 17 60 94 74
2. Merck & Co. (XL, US)   Pharmaceuticals
2. Merck & Co. (XL, US)   Pharmaceuticals 30 62 76 72
3. Akorn (M, US)   Pharmaceuticals
3. Akorn (M, US)   Pharmaceuticals 76 78 46 67
4. AbbVie (XXL, US)   Biotechnology
4. AbbVie (XXL, US)   Biotechnology 51 88 16 58
5. SciClone Pharmaceuticals (XS, US)   Pharmaceuticals
5. SciClone Pharmaceuticals (XS, US)   Pharmaceuticals 73 67 46 56
6. Amphastar (XS, US)   Pharmaceuticals
6. Amphastar (XS, US)   Pharmaceuticals 49 89 31 56
7. Vivus (XS, US)   Pharmaceuticals
7. Vivus (XS, US)   Pharmaceuticals 41 22 100 56
8. Phibro Animal (S, US)   Pharmaceuticals
8. Phibro Animal (S, US)   Pharmaceuticals 91 31 25 56
9. Heska (XS, US)   Pharmaceuticals
9. Heska (XS, US)   Pharmaceuticals 17 94 25 56
10. Pfizer (XL, US)   Pharmaceuticals
10. Pfizer (XL, US)   Pharmaceuticals 36 52 55 50

January 6, 2017. Top 10s are published weekly by . ()

This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from January 6, 2017.

Top 10 Stock History D.J. US Pharmaceutical